A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis
Clinical trial NCT01320332 · COMPLETED
Trial details
- NCT number
- NCT01320332
- Sponsor
- Telsar Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-08-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.